The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

a study on Androgen Insensitivity Syndrome Scoliosis

Summary

Eligibility
for people ages 10-18 (full criteria)
Location
at UCSF
Dates
study started
study ends around
Principal Investigator
by Ishaan Swarup, MD (ucsf)
Headshot of Ishaan Swarup
Ishaan Swarup

Description

Summary

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery.

The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

Keywords

Adolescent Idiopathic Scoliosis (AIS), Neuromuscular Scoliosis, Adolescent Idiopathic Scoliosis, posterior spinal fusion, pain management, Agnosia, Ropivacaine Hydrocloride

Eligibility

You can join if…

Open to people ages 10-18

You CAN'T join if...

  • Patients with forms of scoliosis other than AIS or NM Scoliosis.
  • Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery
  • Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids

Location

  • University of California San Francisco accepting new patients
    San Francisco California 94158 United States

Lead Scientist at University of California Health

  • Ishaan Swarup, MD (ucsf)
    Dr. Ishaan Swarup serves as Chief of Pediatric Orthopaedic Surgery at UCSF. He is a fellowship-trained pediatric orthopaedic surgeon who evaluates and treats infants, children, and young adults with a wide spectrum of musculoskeletal conditions. His areas of expertise include pediatric hip disorders and hip preservation, scoliosis and spinal disorders, and pediatric trauma.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07561827
Phase
Phase 3 research study
Study Type
Interventional
Participants
Expecting 42 study participants
Last Updated
Contact us about this trial